Company intelligence / Profile preview

Oncovolution LLC

Mansfield, Massachusetts, United Statesoncovolution.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Oncovolution is developing a new generation of platinum-based chemotherapeutic agents to increase efficacy and reduce toxicity compared to current cancer treatments. The company is working on optimizing several lead candidates to undergo preclinical studies.

Therapeutic areas: Oncology
Modalities: Platinum-based chemotherapeutic agents
Industry: Biotech

Drug pipeline

3 assets

ONCO-003

Pre-clinical

Indications: Small cell lung carcinoma, Bladder cancer, Ovarian cancer, Testicular cancer

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Oncovolution LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncovolution LLC.

Explore the full profile